Skip to content
Navigate to homepage - Cerba Research

Flow Cytometry Biomarkers and Panels

We develop and validate assays as well as creating drug-specific flow cytometry panels tailored specifically to your study. Find out how we can support your research. 

A Network of Flow Cytometry Experts

Our dedicated flow cytometry  team works closely with you to develop customized panels. Our experts interpret your complex data, offering invaluable insights into your clinical research. 

We are dedicated to continually expanding and improving our flow cytometry services worldwide to better support your journey to personalized medicine. In September 2021, we joined forces with ACT Genomics to launch CerbACT Asia, our immuno-oncology center of excellence in Taipei. In addition to cutting-edge flow cytometry technology, CerbACT Asia also provides histopathology, multiplex immuno-histochemistry (IHC), PBMC, and cell isolations. Watch the video below for a tour of the facility. 

Flow Cytometry At Cerba Research: A Global Implementation

Sample Processing

At Cerba Research, we have global expertise in the following sample matrices: – Whole blood in various anticoagulant types – Peripheral blood mononuclear cell (PBMC) isolation using a globally harmonized procedure or ad hoc customization -Bone marrow aspirate and bone marrow mononuclear cell (BMMC) isolation – Customized magnetic bead isolation with expertise in rare populations (i.e. CD138+ cells)

Instrument Standardization

– Same instrument platform globally – Standardized instrument setting per assay – One acquisition template on the instrument per assay

Data analysis

– Centralized data analysis with one analysis template using FCS Express software – Centralized data review by trained Scientists

A Global Implementation

– Benefit from a global flow cytometry capability – Utilizing one SOP for sample processing, validation and assay transfer – Standardized instrument settings for each assay – Centralized data analysis and review

Flow Cytometry at Cerba Research

We Offer Expertise And Custom Solutions On A Global Scale

Custom Solutions

  • Customized assay design 
  • Fit-for-purpose validation (based on CLSI H62 guideline) 
  • Customized data analysis strategy 


Expertise in assay development and validation to: 

  • Monitor  immunophenotyping and cell activation 
  • Evaluate  receptor occupancy of drug 
  • Monitor  and characterize CAR T cells 
  • Assay validated in blood, bone marrow aspirate (BMA) and peripheral blood mononuclear cells (PBMC) 


Scientists with extensive expertise in: 

  • Panel design 
  • Assay development 
  • Assay validation 
  • Data analysis 
  • High-dimensional flow cytometry 

Global Footprint

Global flow cytometry capabilities standardized  through: 

  • SOPs 
  • Validation process 
  • Assay transfer 
  • Instrument platform 
  • Centralized data analysis and review 

Our dedicated flow cytometry team is willing to develop customized panels to your specification, including multiple myeloma panel, don’t hesitate to contact us to know more 

Flow Cytometry Advantages In Immunotherapy Clinical Trials

In precision medicine, every blood sample reveals a patient’s story. Flow cytometry allows researchers to read every word of that story instantly.

Read more

Key features

Related library content

Webinar: The Advantages and Versatility of Flow Cytometry in Clinical Development

The future of therapeutics lies in immunotherapy through biomarkers. One such biomarker analysis technique is Flow Cytometry (FCM). What is FCM’s added value within clinical trials?

Click to watch the webinar

Related Services

Cerba US Expansion Tour VF.00_04_27_19.Still010

Reach out to our flow cytometry team and discover how we can help you advance your research

Contact Us